Adventures in targeted cancer therapy: From tumour hypoxia to the cancer genome

被引：0
作者：
Workman, P. [1 ]
机构：
[1] Inst Canc Res, Canc Res UK, Ctr Canc Therapeut, Haddow Labs, Sutton SM2 5NG, Surrey, England
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：17 / 19
页数：3
相关论文
共 64 条
  • [1] Aboagye EO, 1997, CANCER RES, V57, P3314
  • [2] Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models
    Al-Saffar, NMS
    Troy, H
    Ramírez de Molina, A
    Jackson, LE
    Madhu, B
    Griffiths, JR
    Leach, MO
    Workman, P
    Lacal, JC
    Judson, IR
    Chung, YL
    [J]. CANCER RESEARCH, 2006, 66 (01) : 427 - 434
  • [3] ATRASH B, IN PRESS TETRAHEDRON
  • [4] Phase I pharmacokinetic and pharmacodynarnic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies
    Banerji, U
    O'Donnell, A
    Scurr, M
    Pacey, S
    Stapleton, S
    Asad, Y
    Simmons, L
    Maloney, A
    Raynaud, F
    Campbell, M
    Walton, M
    Lakhani, S
    Kaye, S
    Workman, P
    Judson, I
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4152 - 4161
  • [5] Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models
    Banerji, U
    Walton, M
    Raynaud, F
    Grimshaw, R
    Kelland, L
    Valenti, M
    Judson, I
    Workman, P
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (19) : 7023 - 7032
  • [6] BARRIL X, 2006, BIOORG MED CHEM 0208
  • [7] In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography
    Barthel, H
    Wilson, H
    Collingridge, DR
    Brown, G
    Osman, S
    Luthra, SK
    Brady, F
    Workman, P
    Price, PM
    Aboagye, EO
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (11) : 2232 - 2242
  • [8] Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells
    Beloueche-Babari, M
    Jackson, LE
    Al-Saffar, NMS
    Eccles, SA
    Raynaud, FI
    Workman, P
    Leach, MO
    Ronen, SM
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (01) : 187 - 196
  • [9] Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition
    Beloueche-Babari, M
    Jackson, LE
    Al-Saffar, NMS
    Workman, P
    Leach, MO
    Ronen, SM
    [J]. CANCER RESEARCH, 2005, 65 (08) : 3356 - 3363
  • [10] BENSON C, UNPUB PHASE I TRIAL
1234567